Department of Medicine, Baylor College of Medicine, 1 Baylor Plaza, BCM-285, Houston, TX, 77030, USA.
Medical Care Line and Research Care Line; VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
Clin Rheumatol. 2017 Sep;36(9):2121-2128. doi: 10.1007/s10067-017-3656-z. Epub 2017 Jun 1.
We evaluated the relationship of systolic blood pressure, diastolic blood pressure, pulse pressure, and treatment with antihypertensives with knee osteoarthritis incidence in a US cohort. We performed a longitudinal study (2004-2010) nested within the Osteoarthritis Initiative Study including only individuals without knee osteoarthritis at baseline. Systolic blood pressure, diastolic blood pressure, and pulse pressure were assessed at baseline, 12-, 24-, and 36-month visits. Knee radiographs at baseline, 12-, 24-, 36- and 48-month visits defined radiographic osteoarthritis, Kellgren and Lawrence grade ≥2. We performed logistic regression, adjusting for age, sex, body mass index, NSAID use, number of antihypertensive medications, diabetic medications, and cholesterol medications. One thousand nine hundred and thirty people (6040 observations) were included. Annual incidence rates of radiographic osteoarthritis by systolic blood pressure quartiles (lowest to highest) were 2.1, 3.4, 3.7, and 3.7%. Fully adjusted odds ratios of incident radiographic osteoarthritis (OA) for the 2nd-4th quartiles were 1.6, 1.7, and 1.6 relative to the lowest quartile (p for trend = 0.03). Pulse pressure results were similar. There was no association with diastolic blood pressure. Compared to those not taking any antihypertensive medications, those taking ≥3 had decreased odds (0.4, 0.1-1.0) of developing incident OA. In a US cohort, higher systolic blood pressure and pulse pressure are associated with increased incidence of radiographic knee osteoarthritis while treatment with ≥3 antihypertensive medications was associated with reduced incidence. These findings suggest a new and promising avenue for research on disease modification in knee osteoarthritis.
我们评估了收缩压、舒张压、脉压以及降压治疗与美国队列中膝骨关节炎发病的关系。我们进行了一项纵向研究(2004-2010 年),该研究嵌套在 Osteoarthritis Initiative 研究中,仅包括基线时无膝骨关节炎的个体。在基线、12、24 和 36 个月访视时评估收缩压、舒张压和脉压。基线、12、24、36 和 48 个月访视的膝关节 X 线片定义为放射学骨关节炎,Kellgren 和 Lawrence 分级≥2 级。我们进行了逻辑回归分析,调整了年龄、性别、体重指数、非甾体抗炎药使用、降压药物数量、糖尿病药物和胆固醇药物。共纳入 1930 人(6040 次观察)。按收缩压四分位(从低到高)计算,放射学骨关节炎的年发病率分别为 2.1%、3.4%、3.7%和 3.7%。第 2-4 四分位的新发放射学骨关节炎(OA)的完全调整比值比分别为最低四分位的 1.6、1.7 和 1.6(趋势检验 p = 0.03)。脉压结果相似。与舒张压无关联。与未服用任何降压药物者相比,服用≥3 种降压药物者发生新发 OA 的几率降低(0.4,0.1-1.0)。在一个美国队列中,较高的收缩压和脉压与放射学膝关节骨关节炎发病率增加相关,而服用≥3 种降压药物与发病率降低相关。这些发现为膝关节骨关节炎疾病修饰的研究提供了一个新的、有希望的途径。